Frank D Collins

Title: **The Innovative Contributions of Frank D. Collins**

Introduction

Frank D. Collins, based in Boulder, Colorado, is a notable inventor recognized for his work in the field of neurotrophic proteins. He has made significant contributions to biomedical research and technology through his innovative inventions.

Latest Patents

Frank D. Collins holds one patent titled "Production of biologically active NGF proteins." This invention outlines processes for producing mature human members of the NGF/BDNF family of neurotrophic proteins that are fully biologically active. Additionally, the patent discloses the gene encoding human BDNF and introduces a previously unreported member of the NGF/BDNF family, known as NGF-3, along with a portion of the gene encoding for NGF-3.

Career Highlights

Collins is associated with Amgen Inc., a leading biotechnology company. His work has been pivotal in enhancing the understanding and production of neurotrophic proteins, which play crucial roles in neuronal growth, survival, and differentiation. His innovative research positions him as a significant figure in the intersection of biotechnology and neuroscience.

Collaborations

Throughout his career, Collins has collaborated with esteemed colleagues such as Jack Lile and Susan Becktesh. These partnerships highlight the team-oriented nature of research in the biotechnology sector, as collaboration often leads to groundbreaking discoveries and advancements.

Conclusion

Frank D. Collins is an exemplary inventor whose contributions to the field of neurotrophic proteins underscore the importance of innovation in biotechnology. His work not only furthers scientific knowledge but also opens new pathways for therapeutic applications in neuroscience.